Option Care Health
OPCH· Services· Fiscal year ends in December
John C. Rademacher is the CEO of Option Care Health and was paid $9.3M in FY2025 (Dec).
Executives6
See all- 1John C. RademacherPresident and Chief Executive OfficerFY2025
- 2Luke WhitworthChief Operating OfficerFY2025
- 3Michael ShapiroFormer Chief Financial OfficerFY2025
- 4Collin G. SmyserGeneral Counsel and Corporate SecretaryFY2025
- 5Christopher L. GrashoffChief Growth OfficerFY2025
- 6Meenal A. SethnaChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allOption Care Health paid its 6 named executives $22.4M in total in FY2025 (Dec). CEO John C. Rademacher was paid $9.3M of that.
| Name | |||
|---|---|---|---|
| John C. RademacherPresident and Chief Executive Officer | Not disclosed | Not disclosed | |
| Luke WhitworthChief Operating Officer | Not disclosed | Not disclosed | |
| Michael ShapiroFormer Chief Financial Officer | Not disclosed | ||
| Collin G. SmyserGeneral Counsel and Corporate Secretary | Not disclosed | ||
| Christopher L. GrashoffChief Growth Officer | Not disclosed | Not disclosed | |
| Meenal A. SethnaChief Financial Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers17
See allThe FY2025 (Dec) proxy of Option Care Health names 17 peer companies for pay. Among Option Care Health and these peers, CEO pay was the lowest of 6 and total shareholder return was 2nd highest of 6.
6th highest of 6in Option Care Health and its pay peers, FY2025 (Dec) by CEO pay:
2nd highest of 6in Option Care Health and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 8, 2026 | FY2025 |
| Annual report | 10-K | Feb 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 2, 2025 | FY2024 |
| Annual report | 10-K | Feb 26, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 3, 2024 | FY2023 |
| Annual report | 10-K | Feb 22, 2024 | FY2023 |